Guidance to sponsors on how to manage clinical trials during the COVID-19 pandemic

Guidance to sponsors on how to manage clinical trials during the COVID-19 pandemic

BioResearch is following  new recommendations for sponsors on how to manage the conduct of clinical trials in the context of the coronavirus disease (COVID-19) pandemic, published by  The European Commission, the European Medicines Agency (EMA) and national Head of Medicines Agencies (HMA). Please click below link for details.

Go back

News

Publication in the Biotechnology magazine

We invite you to read our publication in the Biotechnology magazine - the largest industry portal in Poland, the latest information from the sectors: biotechnology, cosmetology, pharmacy and technologies.

Read more …

Promising antidiabetic drug

We have started an interesting study with a promising antidiabetic drug. The drug is designed in the form of prolonged-action tablets, which action leads to increased insulin secretion.

 

Read more …

Guidance to sponsors on how to manage clinical trials during the COVID-19 pandemic

BioResearch is following  new recommendations for sponsors on how to manage the conduct of clinical trials in the context of the coronavirus disease (COVID-19) pandemic..

Read more …

About Us | Services | Our Site | Partners | Smoking Risk Study | Contact Us

Early Phase Clinical Trials

2020 © Bio Research Group. All rights reserved.

 

scroll to top ▲